- Home
- EZPW vs QURE Comparison
EZPW vs QURE Comparison
Compare EZPW & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EZPW
- QURE
- Stock Information
- Founded
- EZPW 1989
- QURE 1998
- Country
- EZPW United States
- QURE Netherlands
- Employees
- EZPW N/A
- QURE N/A
- Industry
- EZPW Other Specialty Stores
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- EZPW Consumer Discretionary
- QURE Health Care
- Exchange
- EZPW Nasdaq
- QURE Nasdaq
- Market Cap
- EZPW 814.0M
- QURE 725.4M
- IPO Year
- EZPW 1991
- QURE 2007
- Fundamental
- Price
- EZPW $14.25
- QURE $14.62
- Analyst Decision
- EZPW Strong Buy
- QURE Strong Buy
- Analyst Count
- EZPW 3
- QURE 10
- Target Price
- EZPW $19.33
- QURE $37.20
- AVG Volume (30 Days)
- EZPW 821.6K
- QURE 1.1M
- Earning Date
- EZPW 07-30-2025
- QURE 07-31-2025
- Dividend Yield
- EZPW N/A
- QURE N/A
- EPS Growth
- EZPW 18.94
- QURE N/A
- EPS
- EZPW 1.19
- QURE N/A
- Revenue
- EZPW $1,202,458,000.00
- QURE $20,201,000.00
- Revenue This Year
- EZPW $9.25
- QURE N/A
- Revenue Next Year
- EZPW $6.38
- QURE $278.91
- P/E Ratio
- EZPW $12.01
- QURE N/A
- Revenue Growth
- EZPW 8.14
- QURE 6.30
- 52 Week Low
- EZPW $9.80
- QURE $4.45
- 52 Week High
- EZPW $16.60
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- EZPW 60.14
- QURE 50.64
- Support Level
- EZPW $13.34
- QURE $14.03
- Resistance Level
- EZPW $14.25
- QURE $15.16
- Average True Range (ATR)
- EZPW 0.38
- QURE 0.63
- MACD
- EZPW 0.08
- QURE 0.02
- Stochastic Oscillator
- EZPW 98.91
- QURE 67.88
About EZPW EZCORP Inc. Non Voting
EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buy and sell second-hand goods. The operating segments of the company are us Pawn, Latin America Pawn, and other international. us Pawn segment includes all pawn activities in the United States. Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales which are primarily collateral forfeited from pawn lending operations and used merchandise purchased from the customers.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.